Although PYK2 does not directly participate in the pathogenesis of EC, it plays a pivotal role in ESCC progression as a scaffold protein that facilitates c-Abl-mediated activation of NOX5 within the PYK2/NOX5 complex. This evidence concerns the gene NOX5 and esophageal squamous cell carcinoma.